Maternal and perinatal outcomes of a venous thromboembolism high-risk cohort using a multidisciplinary treatment approach
dc.contributor.author | Ernst, Daniel M. | |
dc.contributor.author | Oporto, Joaquin I. | |
dc.contributor.author | Zuniga, Pamela A. | |
dc.contributor.author | Pereira, Jaime I. | |
dc.contributor.author | Vera, Claudio M. | |
dc.contributor.author | Carvajal, Jorge A. | |
dc.date.accessioned | 2025-01-20T23:53:39Z | |
dc.date.available | 2025-01-20T23:53:39Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Objective To evaluate the maternal and perinatal outcomes in a cohort of pregnant women at high risk of venous thromboembolism (VTE). | |
dc.description.abstract | Methods Women at high risk of VTE were evaluated in a multidisciplinary program using a complete diagnostic workup, and specific prophylactic or therapeutic treatment. | |
dc.description.abstract | Results Women were considered at high risk of VTE in 57% (85/148) because of prior (75) or current (10) thromboembolism, and in 27% (40/148) of the cases due to adverse obstetric history. Thrombophilia was diagnosed in 57% of the cases (85/148), either in patients with previous thromboembolism (48%, 41/85) or without a history of thrombosis (70%, 44/63). The most common thrombophilia was antiphospholipid syndrome in 34% (29/85) of the cases. Under respective prophylactic or therapeutic treatment, there were no VTE during pregnancy (0%, 0/148), whereas four events occurred during the puerperium (3%, 4/148). An adverse obstetric outcome was present in 5% (7/148) of all pregnancies, with four early spontaneous abortions (3%, 4/148) and three late miscarriages (2%, 3/148). | |
dc.description.abstract | Conclusion Pregnant women at high risk of VTE can be effectively managed using a risk-adapted treatment. Our results support prospective enrollment and a multidisciplinary assessment of VTE in high-risk pregnant women. | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1002/ijgo.13628 | |
dc.identifier.eissn | 1879-3479 | |
dc.identifier.issn | 0020-7292 | |
dc.identifier.uri | https://doi.org/10.1002/ijgo.13628 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/94983 | |
dc.identifier.wosid | WOS:000619771900001 | |
dc.issue.numero | 3 | |
dc.language.iso | en | |
dc.pagina.final | 507 | |
dc.pagina.inicio | 500 | |
dc.revista | International journal of gynecology & obstetrics | |
dc.rights | acceso restringido | |
dc.subject | acquired thrombophilias | |
dc.subject | antiphospholipid syndrome | |
dc.subject | low‐ | |
dc.subject | molecular‐ | |
dc.subject | weight heparin | |
dc.subject | perinatal outcome | |
dc.subject | pregnancy | |
dc.subject | thromboprophylaxis | |
dc.subject | venous thromboembolism | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Maternal and perinatal outcomes of a venous thromboembolism high-risk cohort using a multidisciplinary treatment approach | |
dc.type | artículo | |
dc.volumen | 154 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |